Localized pelvic neuroblastoma: Excellent survival and low morbidity with tailored therapy - The 10-year experience of the French Society Of Pediatric Oncology

Journal of Clinical Oncology

Volumn 22, Issue 9, 2004, Pages 1689-1695

  Leclair, Marc David ^a   Hartmann, Olivier ^a   Heloury, Yves ^a   Fourcade, Laurent ^a   Laprie, Anne ^a   Mechinaud, Françoise ^a   Munzer, Caroline ^a   Rubie, Herve ^a  

^a Hopital Mere Enfant CHU de Nantes   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; VINCRISTINE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FOLLOW UP; HUMAN; MEDICAL SOCIETY; MINIMAL RESIDUAL DISEASE; MORBIDITY; NEUROBLASTOMA; NEUROLOGIC DISEASE; PELVIS TUMOR; PREOPERATIVE CARE; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME; ADJUVANT THERAPY; ADOLESCENT; CLINICAL TRIAL; FEMALE; INFANT; MALE; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; NEWBORN; PATHOLOGY; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL; TUMOR RECURRENCE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; MALE; MORBIDITY; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEUROBLASTOMA; PELVIC NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 2442636776     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.04.069     Document Type: Article

References (31)

1. Bernstein ML, Leclerc JM, Bunin G, et al: A population-based study of neuroblastoma incidence, survival, and mortality in North America. J Clin Oncol 10:323-329, 1992
2. Cruccetti A, Kiely EM, Spitz L, et al: Pelvic neuroblastoma: Low mortality and high morbidity. J Pediatr Surg 35:724-728, 2000
3. Rubie H, Hartmann O, Michon J, et al: N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: Results of the french NBL90 Study. J Clin Oncol 15:1171-1182, 1997
4. Garaventa A, de Bernardi B, Pianca C, et al: Localized but unresectable neuroblastoma: Treatment and outcome of 145 cases. J Clin Oncol 11:1770-1779, 1993
5. Haase GM, Wong KY, de Lorimier AA, et al: Improvement in survival after excision of primary tumor in stage III neuroblastoma. J Pediatr Surg 24:194-200, 1989
6. Le Tourneau JN, Bernard JL, Hendren WH, et al: Evaluation of the role of surgery in 130 patients with neuroblastoma. J Pediatr Surg 20: 244-249, 1985
7. O'Neill JA, Littman P, Blitzer P, et al: The role of surgery in localized neuroblastoma. J Pediatr Surg 20:708-712, 1985
8. McEwan AJ, Shapiro B, Sisson JC, et al: Radio-iodobenzylguanidine for the scintigraphic location and therapy of adrenergic tumors. Semin Nucl Med 25:132-153, 1985
9. Bertani-Dziedzic L, Dziedzic SW, Gitlow SE: Catecholamine metabolism in neuroblastoma, in Pochedly C (ed): Neuroblastoma: Tumor Biology and Therapy. Boca Raton, FL, CRC, 1990, pp 69-90
10. Shuster JH, McWilliams NB, Castelberry R, et al: Serum lactate dehydrogenase in childhood neuroblastoma. Am J Clin Oncol 15:295-303, 1992
11. Hahn HWL, Levy HM, Evans AE, et al: Serum ferritin as a guide to therapy in neuroblastoma. Cancer Res 40:1411-1413, 1980
12. Shimada H, Ambros IM, Dehner LP, et al: Terminology and morphologic criteria of neuroblastic tumors. Cancer 86:349-363, 1999
13. American Joint Committee. Neuroblastoma, in Beahrs OH, Myers MH (eds): Manual of Staging of Cancer. Philadelphia, PA, Lippincott, 1983, pp 237-239
14. Brodeur GM, Pritchard J, Berthold F, et al: Revisions of the International Criteria for Neuroblastoma Diagnosis, Staging, and Response to treatment. J Clin Oncol 11:1466-1477, 1993
15. Seeger RC, Brodeur GM, Sather H, et al: Association of multiple copies of N-Myc oncogene with rapid progression of neuroblastomas. N Engl J Med 318:1111-1116, 1985
16. Rubie H, Michon J, Plantaz D, et al: Unresectable localized neuroblastoma: Improved survival after primary chemotherapy including carboplatin-etoposide. Br J Cancer 77:2310-2317, 1998
17. Peto R, Pike MC, Armitage P, et al: Design and analysis of clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35:1-39, 1977
18. Kaplan EL, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
19. Cox DR: The analysis of binary data. London, UK, Chapman & Hall, 1977
20. Haase GM, O'Leary MC, Stram DO, et al: Pelvic neuroblastoma: Implications for a new favorable subgroup-A Children's Cancer Group experience. Ann Surg Oncol 2:516-523, 1995
21. De Bernardi B, Conte M, Mancini A, et al: Localized resectable neuroblastoma: Results of the second study of the Italian Cooperative Group for Neuroblastoma. J Clin Oncol 13:884-893, 1995
22. Ghazali S: Pelvic neuroblastoma: A better prognosis. Ann Surg 179:115-118, 1974
23. Yamataka A, Fujiwara T, Tsuchioka T, et al: Pelvic neuroblastoma safety excised using a combination of the abdominal and posterior sagittal routes. J Pediatr Surg 31:223-224, 1996
24. Peña A, Devries PA: Posterior sagittal anorectoplasty: Important technical considerations and new applications. J Pediatr Surg 17:796-811, 1982
25. Frappaz D, Michon J, Hartmann O, et al: Etoposide and Carboplatin in neuroblastoma: A French Society of Pediatric Oncology phase II study. J Clin Oncol 10:1592-1601, 1992
26. Evans AE, d'Angio GJ, Koop CE: The role of multimodal therapy in patients with local and regional neuroblastoma. J Pediatr Surg 19:77-80, 1984
27. Matthay KK, Sather HN, Seeger RC, et al: Excellent outcome of stage II neuroblastoma is independant of residual disease and radiation therapy. J Clin Oncol 7:236-244, 1989
28. Haase GM, O'Leary MC, Ramsay MK, et al: Aggressive surgery combined with intensive chemotherapy improves survival in poor-risk neuroblastoma. J Pediatr Surg 26:1119-1124, 1991
29. Schmidt ML, Lukens JN, Seeger RC, et al: Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study. J Clin Oncol 18: 1260-1268, 2000
30. Coze C, Hartmann O, Michon J, et al: NB87 Induction protocol for stage four neuroblastoma in children over 1 year of age: A report from the French Society of Pediatric Oncology. J Clin Oncol 15:3433-3440, 1997
31. Cotterill SJ, Pearson AD, Pritchard J, et al: Clinical prognostic factors in 1,277 patients with neuroblastoma: Results of the European Neuroblastoma Study Group "Survey" 1982-1992. Eur J Cancer 36:901-908, 2000